Thuja Capital Management
Thuja manages several venture capital funds aimed at building and scaling companies with a prime focus on therapeutics and medical devices. They invest in healthcare innovation, from start-up to scale-up, supporting the development of novel therapies in areas of high unmet medical need.
📥 Buy Full VC Dataset
Offices: Utrecht (The Netherlands)
Investment Stages: Seed, Series A, Series B
Markets: therapeutics, medical devices, BioTech
Founded Year: 2006
Investor Type: Venture Capital
Portfolio Companies: Alesta, Alveron, Artica, Astrivax, Atro, CardiacBooster, Cristal, Esobiotec, FundamentalPharma, Gradient, Indigo, Innosign, NutriLeads, PanCanCert, Salvia, Synerkine, Tacalyx, Argenx, Bioceros, DCprime, Mellon, Milabs, NightBalance, Okapi
Website: https://www.thujacapital.com
Team Page: https://www.thujacapital.com/team-investment-management
Portfolio Link: https://www.thujacapital.com/portfolio
LinkedIn: https://nl.linkedin.com/company/thuja-capital
Twitter: http://twitter.com/ThujaCapital
Crunchbase: https://www.crunchbase.com/organization/thuja-capital
Comments
No comments yet. Be the first to comment!